Spero Licenses Innovent Anti-CD40L Antibody
Spero Therapeutics licensed ex-Greater China rights to SP001, also known as IBI355, a Phase 2-ready third-generation Fc-silent anti-CD40L antibody from Innovent Biologics. The transaction gives Spero global rights outside Greater China, while Innovent retains…
